Galapagos NV
GLPG
#4563
Rank
โ‚ฌ1.81 B
Marketcap
27,13ย โ‚ฌ
Share price
-0.57%
Change (1 day)
6.42%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -โ‚ฌ0.47 Billion

According to Galapagos NV's latest financial reports the company's current earnings are โ‚ฌ0.32 Billion. In 2024 the company made an earning of -โ‚ฌ3.09 Million, an increase over its 2023 earnings that were of -โ‚ฌ29.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.47 Billion14916.3%
2024 -โ‚ฌ3.09 Million-89.44%
2023 -โ‚ฌ29.22 Million-86.42%
2022 -โ‚ฌ0.22 Billion74.92%
2021 -โ‚ฌ0.13 Billion-60.87%
2020 -โ‚ฌ0.32 Billion-309.49%
2019 โ‚ฌ0.15 B-613.74%
2018 -โ‚ฌ29.21 Million-74.71%
2017 -โ‚ฌ0.12 Billion-312.93%
2016 โ‚ฌ54.24 M-145.35%
2015 -โ‚ฌ0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
โ‚ฌ11.24 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚ฌ27.82 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ7.81 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚ฌ1.42 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-โ‚ฌ76.4 Million-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ6.98 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.52 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚ฌ8.00 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ19.83 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA